Loadings, trends, comparisons, and fate of achiral and chiral pharmaceuticals in wastewaters from urban tertiary and rural aerated lagoon treatments

Water Research

Volumn 44, Issue 2, 2010, Pages 533-544

  MacLeod, Sherri L ^a   Wong, Charles S ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF WINNIPEG   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EFFLUENT TREATMENT; EFFLUENTS; LAKES; RURAL AREAS; WASTEWATER TREATMENT;

AERATED LAGOONS; ALBERTA; CHIRAL PHARMACEUTICALS; EFFLUENT CONCENTRATIONS; ENANTIOMER FRACTIONS; PASSIVE SAMPLERS; TERTIARY WASTEWATER TREATMENT; TIME-WEIGHTED AVERAGES; TREATED WASTEWATER; WASTE WATER TREATMENT PLANTS;

PHOTOLYSIS;

ANTIBIOTIC AGENT; ATENOLOL; CARBAMAZEPINE; CELECOXIB; CITALOPRAM; CLARITHROMYCIN; CODEINE; DICLOFENAC; ERYTHROMYCIN; GEMFIBROZIL; METOPROLOL; NAPROXEN; PAROXETINE; PROPRANOLOL; SOTALOL; TEMAZEPAM; TRICLOSAN; TRIMETHOPRIM;

BIOTRANSFORMATION; CONCENTRATION (COMPOSITION); DRUG; LAGOON; PHOTOLYSIS; WASTEWATER;

AERATION; ARTICLE; BIOTRANSFORMATION; EFFLUENT; ENVIRONMENTAL MONITORING; LAGOON; LOW TEMPERATURE; PHOTOLYSIS; PREDICTION; PRIORITY JOURNAL; RURAL AREA; URBAN AREA; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT; WINTER;

ALBERTA; CANADA;

EID: 75849117742     PISSN: 00431354     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.watres.2009.09.056     Document Type: Article

References (59)

1. Alberta Capital Region Wastewater Commission (2009). http://www.acrwc.ab.ca accessed February 25
2. Alvarez D.A., Petty J.D., Huckins J.N., Jones-Lepp T.L., Getting D.T., Goddard J.P., and Manahan S.E. Development of a passive, in situ, integrative sampler for hydrophilic organic contaminants in aquatic environments. Environ. Toxicol. Chem. 23 (2004) 1640-1648
3. Andreozzi R., Raffaele M., and Nicklas P. Pharmaceuticals in STP effluents and their solar photodegradation in the aquatic environment. Chemosphere 50 (2003) 1319-1330
4. Batt A.L., Kim S., and Aga D.S. Comparison of the occurrence of antibiotics in four full-scale wastewater treatment plants with varying designs and operations. Chemosphere 68 (2007) 428-435
5. Bourne G.R. The metabolism of β-adrenoreceptor blocking drugs. In: Bridges J.W., and Chasseaud L.F. (Eds). Progress in Drug Metabolism 6 (1981), John Wiley & Sons Ltd 77-110
6. Carballa M., Omil F., Ternes T., and Lema J.M. Fate of pharmaceutical and personal care products (PPCPs) during anaerobic digestion of sewage sludge. Water Res. 41 (2007) 2139-2150
7. Chen M., Ohman K., Metcalfe C., Ikonomou M.G., Amatya P.L., and Wilson J. Pharmaceuticals and endocrine disruptors in wastewater treatment effluents and in the water supply system of Calgary, Alberta, Canada. Water Qual. Res. J. Can. 41 (2006) 351-364
8. City of Edmonton (2009). http://www.edmonton.ca accessed February 25
9. Coetsier C.M., Spinelli S., Lin L., Roig B., and Touraud E. Discharge of pharmaceutical products (PPs) through a conventional biological sewage treatment plant: MECs vs PECs?. Environ. Int 35 (2009) 787-792
10. Conkle J.L., White J.R., and Metcalfe C.D. Reduction of pharmaceutically active compounds by a lagoon wetland wastewater treatment system in Southeast Louisiana. Chemosphere 73 (2008) 1741-1748
11. Daughton C.G., and Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ. Health. Perspect 107 (1999) 907-938
12. Duigou, E., 2006. Town of Lac La Biche, Personal communication.
13. EMEA. Note for guidance on environmental risk assessment of medicinal products for human use. The European Agency for the Evaluation of Medicinal Products (EMEA) (2006) CMPC/SWP/4447/00
14. Environment Canada (2009). http://www.ec.gc.ca/soer-ree/English/Indicator_series/new_issues.cfm?issue_id=7&tech_id=28#bio_pic accessed February 27
15. Fent K., Weston A.A., and Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol 76 (2006) 122-159
16. Fono L.J., and Sedlak D.L. Use of the chiral pharmaceutical propranolol to identify sewage discharges into surface waters. Environ. Sci. Technol 39 (2005) 9244-9252
17. Fono L.J., Kolodziej E.P., and Sedlak D.L. Attenuation of wastewater-derived contaminants in a effluent-dominated river. Environ. Sci. Technol 40 (2006) 7257-7262
18. Göbel A., McArdell C.S., Joss A., Siegrist H., and Giger W. Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment methodologies. Sci. Total Environ 372 (2007) 361-371
19. Göbel A., Thomsen A., McArdell C.S., Joss A., and Giger W. Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environ. Sci. Technol 39 (2005) 3981-3989
20. Halling-S∅rensen B., Nielsen S.N., Lanzky P.F., Ingerslev F., Holten-Lützh∅ft H.C., and J∅rgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 36 (1998) 357-393
21. Harner T., Wiberg K., and Norstrom R. Enantiomer fractions are preferred to enantiomer ratios for describing chiral signatures in environmental analysis. Environ. Sci. Technol 34 (2000) 218-220
22. Hua W.Y., Bennett E.R., Miao X.-S., Metcalfe C.D., and Letcher R.J. Seasonality effects on pharmaceuticals and s-triazine herbicides in wastewater effluent and surface water from the Canadian side of the Upper Detroit River. Environ. Toxicol. Chem. 25 (2006) 2356-2365
23. Ikehata K., El-Din M.G., and Snyder S.A. Ozonation and advanced oxidation treatment of emerging organic pollutants in water and wastewater. Ozone Sci. Eng 30 (2008) 21-26
24. Jones-Lepp T.L., Alvarez D.A., Petty J.D., and Huckins J.N. Polar organic chemical integrative sampling and liquid chromatography-electrospray/ion-trap mass spectrometry for assessing selected prescription and illicit drugs in treated sewage effluents. Arch. Environ. Contam. Toxicol 47 (2004) 427-439
25. Joss A., Zabcynski S., Göbel A., Hoffmann B., Löffler D., McArdell C.S., Ternes T.A., Thomsen A., and Siegrist H. Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. Water Res. 40 (2006) 1686-1696
26. Kim S.-C., and Carlson K. Temporal and spatial trends in the occurrence of human and veterinary antibiotics in aqueous and river sediment matrices. Environ. Sci. Technol 41 (2007) 50-57
27. Kimura K., Hara H., and Watanabe Y. Elimination of selected acidic pharmaceuticals from municipal wastewater by an activated sludge system and membrane bioreactors. Environ. Sci. Technol 41 (2007) 3708-3714
28. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., and Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol 36 (2002) 1202-1211
29. Kurt-Karakus P.B., Bidleman T.F., Muir D.C.G., Cagampan S.J., Struger J., Sverko E., Small J.M., and Jantunen L.M. Chiral current-use herbicides in Ontario streams. Environ. Sci. Technol 42 (2008) 8452-8458
30. Lajeunesse A., Gagnon C., and Sauvé S. Determination of basic antidepressants and their N-desmethyl metabolites in raw sewage and wastewater using solid-phase extraction and liquid chromatography-tandem mass spectrometry. Anal. Chem. 80 (2008) 5325-5333
31. Letzel M., Metzner G., and Letzel T. Exposure assessment of the pharmaceutical diclofenac based on long-term measurements of the aquatic input. Environ. Int 35 (2009) 363-368
32. Lin A.Y.-C., and Reinhard M. Photodegradation of common environmental pharmaceuticals and estrogens in river water. Environ. Toxicol. Chem. 24 (2005) 1303-1309
33. Lin A.Y.-C., Plumlee M.H., and Reinhard M. Natural attenuation of pharmaceuticals and alkylphenol polyethoxylate metabolites during river transport: photochemical and biological transformation. Environ. Toxicol. Chem. 25 (2006) 1458-1464
34. Lishman L., Smyth S.A., Sarafin K., Kleywegt S., Toito J., Peart T., Lee B., Servos M., Beland M., and Seto P. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment. Sci. Total Environ 367 (2006) 544-588
35. Lissemore L., Hao C., Yang P., Sibley P.K., Mabury S., and Solomon K.R. An exposure assessment for selected pharmaceuticals within a watershed in Southern Ontario. Chemosphere 64 (2006) 717-729
36. Loraine G.A., and Pettigrove M.E. Seasonal variations in concentrations of pharmaceuticals and personal care products in drinking water and reclaimed wastewater in Southern California. Environ. Sci. Technol 40 (2006) 687-695
37. MacLeod S.L. Pharmaceutical occurrence and fate in wastewater and receiving surface waters in two Alberta watersheds. PhD dissertation (2009), University of Alberta, Edmonton, Alberta
38. MacLeod S.L., McClure E.L., and Wong C.S. Laboratory calibration and field deployment of the Polar Organic Chemical Integrative Sampler for pharmaceuticals and personal care products in wastewater and surface water. Environ. Toxicol. Chem. 26 (2007) 2517-2529
39. MacLeod S.L., Sudhir P., and Wong C.S. Stereoisomer analysis of wastewater-derived beta-blockers, selective serotonin re-uptake inhibitors, and salbutamol by high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1170 (2007) 23-33
40. Maier N.M., Franco P., and Lindner W. Separation of enantiomers: needs, challenges, perspectives. J. Chromatogr. A 906 (2001) 3-33
41. Managaki S., Murata A., Takada H., Tuyen B.C., and Chiem N.H. Distribution of macrolides, sulfonamides, and trimethoprim in tropical waters: ubiquitous occurrence of veterinary antibiotics in the Mekong Delta. Environ. Sci. Technol 41 (2007) 8004-8010
42. McArdell C.S., Molnar E., Suter M.J.-F., and Giger W. Occurrence and fate of macrolide antibiotics in wastewater treatment plants and in the Glatt Valley Watershed. Switzerland. Environ. Sci. Technol 37 (2003) 5479-5486
43. Mehvar R., and Brocks D.R. Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans. J. Pharm. Pharm. Sci. 4 (2001) 185-200
44. Miao X.-S., Yang J.-J., and Metcalfe C.D. Carbamazepine and its metabolites in wastewater and in biosolids in a municipal wastewater treatment plant. Environ. Sci. Technol 39 (2005) 7469-7475
45. Neumann J. Untersuchungen zur Bioverfügbarkeit und Pharmakokinetik von Sulfasalazin und seinen Metaboliten. PhD thesis (1989), Free University of Berlin
46. Nikolai L.N., McClure E.L., MacLeod S.L., and Wong C.S. Stereoisomer quantification of the β-blocker drugs atenolol, metoprolol, and propranolol in wastewaters by chiral high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1131 (2006) 103-109
47. Sacher F., Ehmann M., Gabriel S., Graf C., and Brauch H.-J. Pharmaceutical residues in the river Rhine-results of a one-decade monitoring programme. J. Environ. Monit. 10 (2008) 664-670
48. Schmekel B., Rydberg I., Norlander B., Sjöswärd K.N., Ahlner J., and Anderson R.G.G. Stereoselective pharmacokinetics of S-salbutamol after administration of the racemate in healthy volunteers. Eur. Respir. J 13 (1999) 1230-1235
49. Shaw M., and Mueller J.F. Time integrative passive sampling: how well do Chemcatchers integrate fluctuating pollutant concentrations?. Environ. Sci. Technol 43 (2009) 1443-1448
50. Siebold, G., 2008. Lac La Biche County, Personal communication.
51. Stamm C., Alder A.C., Fenner K., Hollender J., Kraus M., McArdell C.S., Ort C., and Schneider M.K. Spatial and temporal patterns of pharmaceuticals in the aquatic environment. Geog. Compass 2/3 (2008) 920-955
52. Stanley J.K., Ramirez A.J., Mottaleb M., Chambliss C.K., and Brooks B.W. Enantiospecific toxicity of the β-blocker propranolol to Daphnia magna and Pimephales promelas. Environ. Toxicol. Chem. 25 (2006) 1780-1786
53. Statistics Canada (2009). http://www12.statcan.ca accessed February 25
54. Stülten, D., Zühlke, S., Lamshöft, M., Spiteller, M., 2008. Occurrence of diclofenac and selected metabolites in sewage effluents. Sci. Total Environ 405, 310-316.
55. Vieno N.M., Tuhkanen T., and Kronberg L. Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water. Environ. Sci. Technol 39 (2005) 8220-8226
56. Vasskog, T., Anderssen, T., Pedersen-Bjergaard, S., Kallenborn, R., Jensen, E., 2008. Occurrence of selective serotonin reuptake inhibitors in sewage and receiving waters at Spitsbergen and in Norway. J. Chromatogr. A 1185, 194-205.
57. Wong C.S. Environmental fate processes and biochemical transformations of chiral emerging organic pollutants. Anal. Bioanal. Chem. 386 (2006) 544-558
58. Yu J.T., Bouwer E.J., and Coelhan M. Occurrence and biodegradability studies of selected pharmaceuticals and personal care products in sewage effluent. Agric. Water Mgmt 86 (2006) 72-80
59. Zhang Z., Hibberd A., and Zhou J.L. Analysis of emerging contaminants in sewage effluent and river water: comparison between spot and passive sampling. Anal. Chim. Acta 607 (2008) 37-44